Semaglutides and tirzepatides are typically administered through a once-weekly self-injection
This requires careful self-assessment but can optimize results
First, a quick primer: GLP-1 receptor agonists like semaglutide (found in medications such as Ozempic, Wegovy and an ever-growing list of other pharmaceutical brands), work by mimicking a hormone that helps control blood sugar and appetite
The FDA's adverse event reporting system has documented 489 reports of patients experiencing anxiety, depression, or suicidal thoughts while taking semaglutide medications, including Ozempic [1]
STEP-4 showed that lipid parameters returned toward baseline within 48 weeks of stopping semaglutide 8
Quick Takeaways Cagrilintide is an amylin analog (appetite suppressant), semaglutide is a GLP-1 receptor agonist (incretin hormone)